基于 β-内酰胺酶的电导生物传感器检测，用于蛋白质间相互作用

Executive Industry Relevance

This conductimetric biosensor assay enables real-time, label-free detection of protein-protein interactions through measurable changes in electrical conductance. It supports early-stage target validation by providing quantitative, reproducible readouts that reduce mechanistic ambiguity in antibody-antigen binding studies. The assay’s compatibility with transducer chips and digital readout systems positions it as a scalable tool for discovery biology workflows requiring functional confirmation of biomolecular interactions.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables direct interrogation of therapeutic hypotheses by confirming antigen-antibody binding through functional enzyme activity.
• Operational Value: Provides a homogeneous, wash-and-read format compatible with multiwell transducer arrays for medium-throughput screening.
• Predictive Confidence: Generates quantitative conductance signals that correlate with binding affinity, supporting go/no-go decisions in lead identification.

Screening & Assay Development

• Assay Readiness: Produces standardized, real-time electrical outputs that facilitate assay normalization and inter-laboratory reproducibility.
• Scalability: The transducer chip design allows for parallelization across multiple working electrodes, enabling panel-based antigen profiling.
• Reagent Compatibility: Utilizes stable chimeric proteins and antibiotic substrates that are amenable to large-scale production and storage.

Translational & Preclinical Research

• Translational Continuity: Supports biomarker-aligned validation by detecting antigen engagement in disease-relevant formats.
• Mechanistic De-risking: Confirms functional binding independent of fluorescence or radioactive labels, reducing assay interference risks.
• Preclinical Alignment: Generates quantitative interaction data that can inform dosing and target occupancy models in vivo.

Pipeline & Workflow Integration

The assay fits within the discovery continuum from target validation through lead optimization, where functional confirmation of binding precedes downstream efficacy and safety profiling.

• Discovery Biology: Supports hypothesis-driven screening by validating that selected antibodies engage targets via specific, measurable interactions.
• Screening: Delivers real-time kinetic-like conductance traces that enable discrimination between specific and nonspecific binding events.
• Analytics: Outputs differential conductance measurements that allow quantitative comparison across antibody variants or antigen concentrations.
• Translational Research: Provides binding confirmation data that can be correlated with cellular or tissue-based target engagement assays.
• Enterprise Reuse: The transducer platform can be regenerated and reused across multiple target panels, supporting cost-effective target validation campaigns.

Operational & Enterprise Impact

• Scientific Value: Reduces false positives by requiring functional enzyme activity as a binding-dependent readout.
• Operational Value: Eliminates need for fluorescent labels or radioactive isotopes, simplifying assay workflow and reducing safety overhead.
• Strategic Value: Accelerates target validation timelines by providing immediate, instrument-based feedback on binding events.
• Portfolio Impact: Enables objective comparison of antibody candidates based on quantitative binding strength, supporting risk-adjusted resource allocation.

Implementation Considerations

• Requires expertise in protein engineering to generate functional bifunctional chimeric proteins.
• Dependent on access to computer-controlled potentiostats or multimeters capable of microSiemens-resolution conductance measurements.
• Necessitates optimization of blocking buffers to minimize nonspecific protein adsorption on conductive polymer surfaces.
• Must account for substrate diffusion kinetics when interpreting real-time conductance changes in complex sample matrices.
• Performance may vary with antigen orientation and density on the working electrode, requiring empirical titration for each target.

Biopharma FAQs